Research ArticleClinical Studies

Delayed Radiotherapy for Patients with Localized Prostate Cancer: Validation by Propensity Score Matching

HIDETSUGU NAKAYAMA, AYAE KANEMOTO, KOJI KIKUCHI, KATSUYUKI MATSUKI, MITSURO TOMOBE, SADAMU TSUKAMOTO, HITOSHI TAKESHIMA, YOSHIKO OSHIRO, SHINJI SUGAHARA and KOICHI TOKUUYE
Anticancer Research April 2013, 33 (4) 1629-1633;

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Biochemical progression-free survival estimated by the Kaplan–Meier method. Five-year biochemical progression-free survival in delayed and non-delayed groups were 87.4% (95% confidence interval, CI=69.7-95.1%) and 96.6% (95% CI=89.6-98.9%), respectively. Patients in the delayed group had significantly shorter biochemical progression-free survival compared to the non-delayed group (p=0.03).

Tables

  • Table I.
  • Table II.
  • Table III.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Delayed Radiotherapy for Patients with Localized Prostate Cancer: Validation by Propensity Score Matching
HIDETSUGU NAKAYAMA, AYAE KANEMOTO, KOJI KIKUCHI, KATSUYUKI MATSUKI, MITSURO TOMOBE, SADAMU TSUKAMOTO, HITOSHI TAKESHIMA, YOSHIKO OSHIRO, SHINJI SUGAHARA, KOICHI TOKUUYE
Anticancer Research Apr 2013, 33 (4) 1629-1633;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords